Insomnia exacerbated and Lipodystrophy acquired

Summary:

Lipodystrophy acquired is found among people with Insomnia exacerbated, especially for people who are male, 60+ old.

The study analyzes which people have Lipodystrophy acquired with Insomnia exacerbated. It is created by eHealthMe based on reports of 15 people who have Insomnia exacerbated from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Insomnia exacerbated?

Insomnia exacerbated (severe sleeplessness) is found to be associated with 2,687 drugs and 976 conditions by eHealthMe. Check the latest studies of Insomnia exacerbated.

What is Lipodystrophy acquired?

Lipodystrophy acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired) is found to be associated with 173 drugs and 238 conditions by eHealthMe. Check the latest studies of Lipodystrophy acquired.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

15 people who have Insomnia Exacerbated and Lipodystrophy Acquired are studied.

Would you have Lipodystrophy acquired when you have Insomnia exacerbated?

Gender of people who have Insomnia Exacerbated and experienced Lipodystrophy Acquired *:

female: 26.67 %
male: 73.33 %

Age of people who have Insomnia Exacerbated and experienced Lipodystrophy Acquired *:

Common co-existing conditions for these people *:

Hepatitis C: 9 people, 60.00%
Hiv Infection: 9 people, 60.00%
Nausea (feeling of having an urge to vomit): 8 people, 53.33%
Constipation: 8 people, 53.33%
Cataract (clouding of the lens inside the eye): 6 people, 40.00%
Stress And Anxiety: 3 people, 20.00%
Pain: 3 people, 20.00%
Hiv Test Positive: 2 people, 13.33%
Functional Gastrointestinal Disorder (functional problem in separate organs of gastrointestinal system): 2 people, 13.33%
Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 2 people, 13.33%

Common drugs taken by these people *:

Common symptoms for these people *:

Hepatitis C: 9 people, 60.00%
Nausea (feeling of having an urge to vomit): 9 people, 60.00%
Cataract (clouding of the lens inside the eye): 9 people, 60.00%
Protein Total Increased: 9 people, 60.00%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 9 people, 60.00%
Renal Impairment (severely reduced kidney function): 9 people, 60.00%
Lymphocyte Count Decreased: 9 people, 60.00%
Constipation: 8 people, 53.33%
Stress And Anxiety: 4 people, 26.67%
Fatigue (feeling of tiredness): 4 people, 26.67%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Lipodystrophy acquired?

- Check whether Lipodystrophy acquired is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Lipodystrophy acquired and Insomnia exacerbated, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.